Spire Wealth Management Jazz Pharmaceuticals PLC Transaction History
Spire Wealth Management
- $3.01 Billion
- Q1 2024
A detailed history of Spire Wealth Management transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Spire Wealth Management holds 200 shares of JAZZ stock, worth $20,254. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 56
257.14%
Holding current value
$20,254
Previous $6,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding JAZZ
# of Institutions
514Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$716 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$653 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$249 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$241 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$151 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.35B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...